Thymidylate Synthase Expression, p53, bcl-2, Ki-67 and p27 in Colorectal Cancer: Relationships with Tumor Recurrence and Survival View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2004-12-27

AUTHORS

Gerardo Rosati, Rosistella Chiacchio, Giorgio Reggiardo, Domenico De Sanctis, Luigi Manzione

ABSTRACT

It was the objective to determine in this retrospective study whether thymidylate synthase (TS), p53, bcl-2, Ki-67 and p27 in Dukes' stage B and stage C (AJCC/UICC stage II and III) colorectal adenocarcinoma were predictive of disease-free survival (DFS) and overall survival (OS). Paraffin-embedded specimens from 103 patients with colorectal cancer, treated with surgery between October 1994 and September 1999, were examined for TS expression, p53, bcl-2, Ki-67 and p27 using immunohistochemistry; 51 cases were Dukes' stage B and 52 cases were Dukes' stage C disease. Adjuvant 5-FU-based chemotherapy was given to all patients, while 31 having rectal malignancy also received pelvic radiotherapy. Data were associated with the recurrence rate and survival. With a median follow-up of 5 years, 38 patients (36.8%) developed recurrence and as many patients (36.8%) died. TS was overexpressed in 16 cases (15.6%), p53 nuclear oncoprotein accumulation in >10% of cells occurred more frequently [61 of 103 cases (59.3%)], positive expression of bcl-2 protein in >10% of cells was observed in 41 of 103 cases (39.9%), 57 patients (55.4%) showed immunohistochemical expression of Ki-67 and there were 75 cases (72.9%) with p27 accumulation. The pathological stage was the only independent prognostic factor for DFS (p = 0.042). Sex, as well as age and biological prognostic factors, had no significant impact value on DFS and OS. A multivariate analysis of OS demonstrated that stage C, p53 negative and Ki-67 positive were associated significantly with an unfavorable outcome and a worse median OS (p = 0.035 and t ratio = 2.48). Some biological characteristics such as p53 and Ki-67 status may provide useful prognostic information in addition to the classical clinicopathological parameters. However, further studies are needed to clarify the value of adopting biological prognostic factors into clinical practice. More... »

PAGES

258-263

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1159/000081389

DOI

http://dx.doi.org/10.1159/000081389

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1053456430

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15627889


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ki-67 Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multivariate Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proliferating Cell Nuclear Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins c-bcl-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Suppressor Protein p53", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rosati", 
        "givenName": "Gerardo", 
        "id": "sg:person.01362033743.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362033743.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chiacchio", 
        "givenName": "Rosistella", 
        "id": "sg:person.0606020042.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606020042.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reggiardo", 
        "givenName": "Giorgio", 
        "id": "sg:person.01251446443.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251446443.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Sanctis", 
        "givenName": "Domenico", 
        "id": "sg:person.01050660100.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050660100.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Manzione", 
        "givenName": "Luigi", 
        "id": "sg:person.01260533117.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260533117.65"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6690033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038295854", 
          "https://doi.org/10.1038/sj.bjc.6690033"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690091", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025862764", 
          "https://doi.org/10.1038/sj.bjc.6690091"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2004-12-27", 
    "datePublishedReg": "2004-12-27", 
    "description": "It was the objective to determine in this retrospective study whether thymidylate synthase (TS), p53, bcl-2, Ki-67 and p27 in Dukes' stage B and stage C (AJCC/UICC stage II and III) colorectal adenocarcinoma were predictive of disease-free survival (DFS) and overall survival (OS). Paraffin-embedded specimens from 103 patients with colorectal cancer, treated with surgery between October 1994 and September 1999, were examined for TS expression, p53, bcl-2, Ki-67 and p27 using immunohistochemistry; 51 cases were Dukes' stage B and 52 cases were Dukes' stage C disease. Adjuvant 5-FU-based chemotherapy was given to all patients, while 31 having rectal malignancy also received pelvic radiotherapy. Data were associated with the recurrence rate and survival. With a median follow-up of 5 years, 38 patients (36.8%) developed recurrence and as many patients (36.8%) died. TS was overexpressed in 16 cases (15.6%), p53 nuclear oncoprotein accumulation in >10% of cells occurred more frequently [61 of 103 cases (59.3%)], positive expression of bcl-2 protein in >10% of cells was observed in 41 of 103 cases (39.9%), 57 patients (55.4%) showed immunohistochemical expression of Ki-67 and there were 75 cases (72.9%) with p27 accumulation. The pathological stage was the only independent prognostic factor for DFS (p = 0.042). Sex, as well as age and biological prognostic factors, had no significant impact value on DFS and OS. A multivariate analysis of OS demonstrated that stage C, p53 negative and Ki-67 positive were associated significantly with an unfavorable outcome and a worse median OS (p = 0.035 and t ratio = 2.48). Some biological characteristics such as p53 and Ki-67 status may provide useful prognostic information in addition to the classical clinicopathological parameters. However, further studies are needed to clarify the value of adopting biological prognostic factors into clinical practice.", 
    "genre": "article", 
    "id": "sg:pub.10.1159/000081389", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1091981", 
        "issn": [
          "1010-4283", 
          "1423-0380"
        ], 
        "name": "Tumor Biology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5-6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "25"
      }
    ], 
    "keywords": [
      "disease-free survival", 
      "Dukes' stage B", 
      "stage C disease", 
      "biological prognostic factors", 
      "overall survival", 
      "prognostic factors", 
      "stage B", 
      "colorectal cancer", 
      "Dukes' stage C disease", 
      "only independent prognostic factor", 
      "independent prognostic factor", 
      "useful prognostic information", 
      "thymidylate synthase", 
      "worse median OS", 
      "classical clinicopathological parameters", 
      "Adjuvant 5-FU", 
      "median OS", 
      "Ki-67 status", 
      "pelvic radiotherapy", 
      "retrospective study", 
      "recurrence rate", 
      "tumor recurrence", 
      "rectal malignancies", 
      "pathological stage", 
      "unfavorable outcome", 
      "prognostic information", 
      "colorectal adenocarcinoma", 
      "clinicopathological parameters", 
      "immunohistochemical expression", 
      "synthase expression", 
      "p53 negative", 
      "clinical practice", 
      "patients", 
      "stage C", 
      "multivariate analysis", 
      "TS expression", 
      "Ki-67", 
      "positive expression", 
      "survival", 
      "p27 accumulation", 
      "Further studies", 
      "recurrence", 
      "p27", 
      "cancer", 
      "p53", 
      "Bcl-2", 
      "Bcl-2 protein", 
      "biological characteristics", 
      "expression", 
      "chemotherapy", 
      "surgery", 
      "adenocarcinoma", 
      "cells", 
      "radiotherapy", 
      "malignancy", 
      "cases", 
      "immunohistochemistry", 
      "factors", 
      "disease", 
      "age", 
      "outcomes", 
      "sex", 
      "study", 
      "accumulation", 
      "paraffin", 
      "status", 
      "synthase", 
      "years", 
      "specimens", 
      "negatives", 
      "protein", 
      "rate", 
      "objective", 
      "practice", 
      "stage", 
      "addition", 
      "values", 
      "data", 
      "relationship", 
      "analysis", 
      "characteristics", 
      "information", 
      "parameters", 
      "impact value", 
      "stage C (AJCC/UICC stage II and III) colorectal adenocarcinoma", 
      "C (AJCC/UICC stage II and III) colorectal adenocarcinoma", 
      "C disease", 
      "p53 nuclear oncoprotein accumulation", 
      "nuclear oncoprotein accumulation", 
      "oncoprotein accumulation", 
      "significant impact value"
    ], 
    "name": "Thymidylate Synthase Expression, p53, bcl-2, Ki-67 and p27 in Colorectal Cancer: Relationships with Tumor Recurrence and Survival", 
    "pagination": "258-263", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1053456430"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1159/000081389"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15627889"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1159/000081389", 
      "https://app.dimensions.ai/details/publication/pub.1053456430"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:14", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_393.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1159/000081389"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1159/000081389'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1159/000081389'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1159/000081389'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1159/000081389'


 

This table displays all metadata directly associated to this object as RDF triples.

269 TRIPLES      22 PREDICATES      139 URIs      129 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1159/000081389 schema:about N0ac67c01791748df9cd29696640f687f
2 N1ce69821b0b2406bb8e95904e302a29a
3 N23eac18236784cb5982c67c6c9b04aea
4 N41698ffb16b64d099d2b1df1e691bcc0
5 N57f05654925c4890853c3dda4eed6d34
6 N7687cc3a55c745aabd4646c5c9e7bddf
7 N7a2d356202514ca7b6bfbf60b2262458
8 N914c27c4acb340e19af700bdb2e091a1
9 Na799f0fbdcbd416cb94a3e0e4e61d951
10 Na8c09174cd644c9a9e142e3764ba9d75
11 Nb27137cdd070443e8852da3b30d1c7ae
12 Nb49780f4a3fd4aad9a665cd442fa1757
13 Nbe2970430e124135bc8da7ea502622da
14 Nc1e4e51ec5d14b4daec504346968da44
15 Nd66ac16e09724e75af4e8a4cc47367f0
16 Ne9e289f6b1b644ceb1ce368b41b6b09d
17 Nec532e3895fa4117bb0a6c4cd8dcc10f
18 Nef338187c9324439a38415a7688a6aa6
19 Nf71c4c5be9b44750bfa4caf7e8c9c2ec
20 Nfe3994f91bdf4f75b0681c1d2fb29f7f
21 anzsrc-for:11
22 anzsrc-for:1112
23 schema:author N4665ca6ee46543a4b952e18a7d2a04bc
24 schema:citation sg:pub.10.1038/sj.bjc.6690033
25 sg:pub.10.1038/sj.bjc.6690091
26 schema:datePublished 2004-12-27
27 schema:datePublishedReg 2004-12-27
28 schema:description It was the objective to determine in this retrospective study whether thymidylate synthase (TS), p53, bcl-2, Ki-67 and p27 in Dukes' stage B and stage C (AJCC/UICC stage II and III) colorectal adenocarcinoma were predictive of disease-free survival (DFS) and overall survival (OS). Paraffin-embedded specimens from 103 patients with colorectal cancer, treated with surgery between October 1994 and September 1999, were examined for TS expression, p53, bcl-2, Ki-67 and p27 using immunohistochemistry; 51 cases were Dukes' stage B and 52 cases were Dukes' stage C disease. Adjuvant 5-FU-based chemotherapy was given to all patients, while 31 having rectal malignancy also received pelvic radiotherapy. Data were associated with the recurrence rate and survival. With a median follow-up of 5 years, 38 patients (36.8%) developed recurrence and as many patients (36.8%) died. TS was overexpressed in 16 cases (15.6%), p53 nuclear oncoprotein accumulation in >10% of cells occurred more frequently [61 of 103 cases (59.3%)], positive expression of bcl-2 protein in >10% of cells was observed in 41 of 103 cases (39.9%), 57 patients (55.4%) showed immunohistochemical expression of Ki-67 and there were 75 cases (72.9%) with p27 accumulation. The pathological stage was the only independent prognostic factor for DFS (p = 0.042). Sex, as well as age and biological prognostic factors, had no significant impact value on DFS and OS. A multivariate analysis of OS demonstrated that stage C, p53 negative and Ki-67 positive were associated significantly with an unfavorable outcome and a worse median OS (p = 0.035 and t ratio = 2.48). Some biological characteristics such as p53 and Ki-67 status may provide useful prognostic information in addition to the classical clinicopathological parameters. However, further studies are needed to clarify the value of adopting biological prognostic factors into clinical practice.
29 schema:genre article
30 schema:inLanguage en
31 schema:isAccessibleForFree false
32 schema:isPartOf Nbbe63dd331c74b17864d633a5e7e3496
33 Nc22e2815132a44daa863b678a7cca941
34 sg:journal.1091981
35 schema:keywords Adjuvant 5-FU
36 Bcl-2
37 Bcl-2 protein
38 C (AJCC/UICC stage II and III) colorectal adenocarcinoma
39 C disease
40 Dukes' stage B
41 Dukes' stage C disease
42 Further studies
43 Ki-67
44 Ki-67 status
45 TS expression
46 accumulation
47 addition
48 adenocarcinoma
49 age
50 analysis
51 biological characteristics
52 biological prognostic factors
53 cancer
54 cases
55 cells
56 characteristics
57 chemotherapy
58 classical clinicopathological parameters
59 clinical practice
60 clinicopathological parameters
61 colorectal adenocarcinoma
62 colorectal cancer
63 data
64 disease
65 disease-free survival
66 expression
67 factors
68 immunohistochemical expression
69 immunohistochemistry
70 impact value
71 independent prognostic factor
72 information
73 malignancy
74 median OS
75 multivariate analysis
76 negatives
77 nuclear oncoprotein accumulation
78 objective
79 oncoprotein accumulation
80 only independent prognostic factor
81 outcomes
82 overall survival
83 p27
84 p27 accumulation
85 p53
86 p53 negative
87 p53 nuclear oncoprotein accumulation
88 paraffin
89 parameters
90 pathological stage
91 patients
92 pelvic radiotherapy
93 positive expression
94 practice
95 prognostic factors
96 prognostic information
97 protein
98 radiotherapy
99 rate
100 rectal malignancies
101 recurrence
102 recurrence rate
103 relationship
104 retrospective study
105 sex
106 significant impact value
107 specimens
108 stage
109 stage B
110 stage C
111 stage C (AJCC/UICC stage II and III) colorectal adenocarcinoma
112 stage C disease
113 status
114 study
115 surgery
116 survival
117 synthase
118 synthase expression
119 thymidylate synthase
120 tumor recurrence
121 unfavorable outcome
122 useful prognostic information
123 values
124 worse median OS
125 years
126 schema:name Thymidylate Synthase Expression, p53, bcl-2, Ki-67 and p27 in Colorectal Cancer: Relationships with Tumor Recurrence and Survival
127 schema:pagination 258-263
128 schema:productId N5d16152eac974487a63104b961e667e2
129 N95d9839cc34b40e69bce8b5845253aa6
130 Naca66798d0844b04ae68f8b6e3c4e12d
131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053456430
132 https://doi.org/10.1159/000081389
133 schema:sdDatePublished 2022-01-01T18:14
134 schema:sdLicense https://scigraph.springernature.com/explorer/license/
135 schema:sdPublisher N6c402c1820d24a3ba0882c0c4da380eb
136 schema:url https://doi.org/10.1159/000081389
137 sgo:license sg:explorer/license/
138 sgo:sdDataset articles
139 rdf:type schema:ScholarlyArticle
140 N0ac67c01791748df9cd29696640f687f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Adenocarcinoma
142 rdf:type schema:DefinedTerm
143 N1ce69821b0b2406bb8e95904e302a29a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Ki-67 Antigen
145 rdf:type schema:DefinedTerm
146 N211f264e2ea44314bb6cb0f9905aade3 rdf:first sg:person.01251446443.14
147 rdf:rest N6efb8693217f41179a33d0adc449e04a
148 N23eac18236784cb5982c67c6c9b04aea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Male
150 rdf:type schema:DefinedTerm
151 N41698ffb16b64d099d2b1df1e691bcc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Multivariate Analysis
153 rdf:type schema:DefinedTerm
154 N4665ca6ee46543a4b952e18a7d2a04bc rdf:first sg:person.01362033743.92
155 rdf:rest Nfd0901e46cd44300b6d1a9ab9870a8c6
156 N57f05654925c4890853c3dda4eed6d34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Proto-Oncogene Proteins c-bcl-2
158 rdf:type schema:DefinedTerm
159 N5d16152eac974487a63104b961e667e2 schema:name dimensions_id
160 schema:value pub.1053456430
161 rdf:type schema:PropertyValue
162 N6c402c1820d24a3ba0882c0c4da380eb schema:name Springer Nature - SN SciGraph project
163 rdf:type schema:Organization
164 N6efb8693217f41179a33d0adc449e04a rdf:first sg:person.01050660100.85
165 rdf:rest N9428ae7c17724f83987fecc02752da58
166 N7687cc3a55c745aabd4646c5c9e7bddf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Colorectal Neoplasms
168 rdf:type schema:DefinedTerm
169 N7a2d356202514ca7b6bfbf60b2262458 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Disease-Free Survival
171 rdf:type schema:DefinedTerm
172 N914c27c4acb340e19af700bdb2e091a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Immunohistochemistry
174 rdf:type schema:DefinedTerm
175 N9428ae7c17724f83987fecc02752da58 rdf:first sg:person.01260533117.65
176 rdf:rest rdf:nil
177 N95d9839cc34b40e69bce8b5845253aa6 schema:name doi
178 schema:value 10.1159/000081389
179 rdf:type schema:PropertyValue
180 Na799f0fbdcbd416cb94a3e0e4e61d951 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Retrospective Studies
182 rdf:type schema:DefinedTerm
183 Na8c09174cd644c9a9e142e3764ba9d75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Biomarkers, Tumor
185 rdf:type schema:DefinedTerm
186 Naca66798d0844b04ae68f8b6e3c4e12d schema:name pubmed_id
187 schema:value 15627889
188 rdf:type schema:PropertyValue
189 Nb27137cdd070443e8852da3b30d1c7ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Aged
191 rdf:type schema:DefinedTerm
192 Nb49780f4a3fd4aad9a665cd442fa1757 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Humans
194 rdf:type schema:DefinedTerm
195 Nbbe63dd331c74b17864d633a5e7e3496 schema:issueNumber 5-6
196 rdf:type schema:PublicationIssue
197 Nbe2970430e124135bc8da7ea502622da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Neoplasm Staging
199 rdf:type schema:DefinedTerm
200 Nc1e4e51ec5d14b4daec504346968da44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Tumor Suppressor Protein p53
202 rdf:type schema:DefinedTerm
203 Nc22e2815132a44daa863b678a7cca941 schema:volumeNumber 25
204 rdf:type schema:PublicationVolume
205 Nd66ac16e09724e75af4e8a4cc47367f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Neoplasm Recurrence, Local
207 rdf:type schema:DefinedTerm
208 Ne9e289f6b1b644ceb1ce368b41b6b09d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Middle Aged
210 rdf:type schema:DefinedTerm
211 Nec532e3895fa4117bb0a6c4cd8dcc10f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
212 schema:name Proliferating Cell Nuclear Antigen
213 rdf:type schema:DefinedTerm
214 Nef338187c9324439a38415a7688a6aa6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
215 schema:name Female
216 rdf:type schema:DefinedTerm
217 Nf71c4c5be9b44750bfa4caf7e8c9c2ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Prognosis
219 rdf:type schema:DefinedTerm
220 Nfd0901e46cd44300b6d1a9ab9870a8c6 rdf:first sg:person.0606020042.08
221 rdf:rest N211f264e2ea44314bb6cb0f9905aade3
222 Nfe3994f91bdf4f75b0681c1d2fb29f7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Chemotherapy, Adjuvant
224 rdf:type schema:DefinedTerm
225 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
226 schema:name Medical and Health Sciences
227 rdf:type schema:DefinedTerm
228 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
229 schema:name Oncology and Carcinogenesis
230 rdf:type schema:DefinedTerm
231 sg:journal.1091981 schema:issn 1010-4283
232 1423-0380
233 schema:name Tumor Biology
234 schema:publisher Springer Nature
235 rdf:type schema:Periodical
236 sg:person.01050660100.85 schema:affiliation grid-institutes:None
237 schema:familyName De Sanctis
238 schema:givenName Domenico
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050660100.85
240 rdf:type schema:Person
241 sg:person.01251446443.14 schema:affiliation grid-institutes:None
242 schema:familyName Reggiardo
243 schema:givenName Giorgio
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251446443.14
245 rdf:type schema:Person
246 sg:person.01260533117.65 schema:affiliation grid-institutes:None
247 schema:familyName Manzione
248 schema:givenName Luigi
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260533117.65
250 rdf:type schema:Person
251 sg:person.01362033743.92 schema:affiliation grid-institutes:None
252 schema:familyName Rosati
253 schema:givenName Gerardo
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362033743.92
255 rdf:type schema:Person
256 sg:person.0606020042.08 schema:affiliation grid-institutes:None
257 schema:familyName Chiacchio
258 schema:givenName Rosistella
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606020042.08
260 rdf:type schema:Person
261 sg:pub.10.1038/sj.bjc.6690033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038295854
262 https://doi.org/10.1038/sj.bjc.6690033
263 rdf:type schema:CreativeWork
264 sg:pub.10.1038/sj.bjc.6690091 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025862764
265 https://doi.org/10.1038/sj.bjc.6690091
266 rdf:type schema:CreativeWork
267 grid-institutes:None schema:alternateName Medical Oncology Unit and, Histopathology, ‘S. Carlo’ Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy
268 schema:name Medical Oncology Unit and, Histopathology, ‘S. Carlo’ Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy
269 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...